Literature DB >> 21648952

Major remodelling of the murine stem cell kinome following differentiation in the hematopoietic compartment.

Amy L Hazen1, Sander H Diks, Joseph A Wahle, Gwenny M Fuhler, Maikel P Peppelenbosch, William G Kerr.   

Abstract

The changes in signal transduction associated with the acquisition of specific cell fates remain poorly understood. We performed massive parallel assessment of kinase signatures of the radiations of the hematopoietic system, including long-term repopulating hematopoietic stem cells (LT-HSC), short-term repopulating HSC (ST-HSC), immature natural killer (iNK) cells, NK cells, B cells, T cells, and myeloid cells. The LT-HSC kinome is characterized by noncanonical Wnt, Ca(2+) and classical protein kinase C (PKC)-driven signaling, which is lost upon the transition to ST-HSC, whose kinome signature prominently features receptor tyrosine kinase (RTK) activation of the Ras/MAPK signaling cassette. Further differentiation to iNK maintains signaling through this cassette but simultaneously leads to activation of a PI3K/PKB/Rac signaling, which becomes the dominant trait in the kinase signature following full differentiation toward NK cells. Differentiation along the myeloid and B cell lineages is accompanied by hyperactivation of both the Ras/MAPK and PI3K/PKB/Rac signaling cassette. T cells, however, deactivate signaling and only display residual G protein-coupled pathways. Thus, differentiation along the hematopoietic lineage is associated with major remodelling of cellular kinase signature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21648952      PMCID: PMC3151341          DOI: 10.1021/pr2001594

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  38 in total

1.  Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells.

Authors:  Sander H Diks; Klaartje Kok; Tom O'Toole; Daan W Hommes; Peter van Dijken; Jos Joore; Maikel P Peppelenbosch
Journal:  J Biol Chem       Date:  2004-09-07       Impact factor: 5.157

Review 2.  When pathways collide: collaboration and connivance among signalling proteins in development.

Authors:  Helen McNeill; James R Woodgett
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05-12       Impact factor: 94.444

3.  Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapy.

Authors:  Steven M Kornblau; Mark D Minden; David B Rosen; Santosh Putta; Aileen Cohen; Todd Covey; David C Spellmeyer; Wendy J Fantl; Urte Gayko; Alessandra Cesano
Journal:  Clin Cancer Res       Date:  2010-06-04       Impact factor: 12.531

4.  Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus.

Authors:  Taher E Taher; Kaushal Parikh; Fabian Flores-Borja; Salvinia Mletzko; David A Isenberg; Maikel P Peppelenbosch; Rizgar A Mageed
Journal:  Arthritis Rheum       Date:  2010-08

5.  PhosphoBase, a database of phosphorylation sites: release 2.0.

Authors:  A Kreegipuu; N Blom; S Brunak
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

Review 6.  Unexpected roles for core promoter recognition factors in cell-type-specific transcription and gene regulation.

Authors:  James A Goodrich; Robert Tjian
Journal:  Nat Rev Genet       Date:  2010-07-13       Impact factor: 53.242

7.  Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

Authors:  H L McLeod; D R Miller; W E Evans
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

8.  Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.

Authors:  Gwenny M Fuhler; Gerlinde J Knol; A Lyndsay Drayer; Edo Vellenga
Journal:  J Leukoc Biol       Date:  2004-11-23       Impact factor: 4.962

9.  Single cell profiling of potentiated phospho-protein networks in cancer cells.

Authors:  Jonathan M Irish; Randi Hovland; Peter O Krutzik; Omar D Perez; Øystein Bruserud; Bjørn T Gjertsen; Garry P Nolan
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

10.  Molecular signatures of proliferation and quiescence in hematopoietic stem cells.

Authors:  Teresa A Venezia; Akil A Merchant; Carlos A Ramos; Nathan L Whitehouse; Andrew S Young; Chad A Shaw; Margaret A Goodell
Journal:  PLoS Biol       Date:  2004-09-28       Impact factor: 8.029

View more
  5 in total

1.  Kinome-wide analysis of the effect of statins in colorectal cancer.

Authors:  Sarah Ouahoud; Rutger J Jacobs; Maikel P Peppelenbosch; G M Fühler; Jarom Heijmans; Sander Diks; Manon E Wildenberg; Lukas J A C Hawinkels; Liudmila L Kodach; Philip W Voorneveld; James C H Hardwick
Journal:  Br J Cancer       Date:  2021-03-19       Impact factor: 9.075

2.  PIIKA 2: an expanded, web-based platform for analysis of kinome microarray data.

Authors:  Brett Trost; Jason Kindrachuk; Pekka Määttänen; Scott Napper; Anthony Kusalik
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

3.  Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids.

Authors:  Wesley K Utomo; Marjan de Vries; Henri Braat; Marco J Bruno; Kaushal Parikh; Mònica Comalada; Maikel P Peppelenbosch; Harry van Goor; Gwenny M Fuhler
Journal:  Front Mol Neurosci       Date:  2017-01-24       Impact factor: 5.639

Review 4.  Kinome profiling.

Authors:  Maikel P Peppelenbosch
Journal:  Scientifica (Cairo)       Date:  2012-08-07

5.  Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spots.

Authors:  Jetse Scholma; Gwenny M Fuhler; Jos Joore; Marc Hulsman; Stefano Schivo; Alan F List; Marcel J T Reinders; Maikel P Peppelenbosch; Janine N Post
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.